ASCL1 and neoplasm: In contrast, dCKO showed no incorporation of EdU within tdTOM+ cells at P30 or even in the few terminal-stage dCKO tumors (Supplementary Fig. 3g, h, k, l), indicating that tumor cell proliferation was significantly compromised in the absence of both ASCL1 and OLIG2.